Lifeboat Foundation

Data dashboards have been an important part of pandemic response and planning. What have their developers learnt about communicating science in a crisis?

Circa 2021

Novel fluorescence imaging assay provides new insights for developing more effective cancer nanomedicines.

The creation of new proteins and peptides for use with CRISPR represents the next stage in the evolution of this technology.

𝙇𝙤𝙪 𝙂𝙚𝙝𝙧𝙞𝙜’𝙨 𝙙𝙞𝙨𝙚𝙖𝙨𝙚—𝙖𝙢𝙮𝙤𝙩𝙧𝙤𝙥𝙝𝙞𝙘 𝙡𝙖𝙩𝙚𝙧𝙖𝙡 𝙨𝙘𝙡𝙚𝙧𝙤𝙨𝙞𝙨 (𝘼𝙇𝙎)—𝙞𝙨 𝙖 𝙣𝙞𝙜𝙝𝙩𝙢𝙖𝙧𝙚 𝙞𝙣 𝙞𝙩𝙨 𝙖𝙙𝙫𝙖𝙣𝙘𝙚𝙙 𝙛𝙤𝙧𝙢, 𝙡𝙚𝙖𝙫𝙞𝙣𝙜 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙨 𝙬𝙞𝙩𝙝𝙤𝙪𝙩 𝙖𝙣𝙮 𝙢𝙚𝙖𝙣𝙨 𝙤𝙛 𝙘𝙤𝙢𝙢𝙪𝙣𝙞𝙘𝙖𝙩𝙞𝙣𝙜 𝙩𝙝𝙚𝙞𝙧 𝙣𝙚𝙚𝙙𝙨 𝙖𝙣𝙙 𝙬𝙞𝙨𝙝𝙚𝙨. 𝘽𝙪𝙩 𝙖 𝙣𝙚𝙬 𝙗𝙧𝙖𝙞𝙣 𝙞𝙢𝙥𝙡𝙖𝙣𝙩 𝙝𝙖𝙨 𝙖𝙡𝙡𝙤𝙬𝙚𝙙 𝙖 34-𝙮𝙚𝙖𝙧-𝙤𝙡𝙙 𝙡𝙤𝙘𝙠𝙚𝙙-𝙞𝙣 𝘼𝙇𝙎 𝙥𝙖𝙩𝙞𝙚𝙣𝙩 𝙩𝙤 𝙧𝙚𝙜𝙖𝙞𝙣 𝙝𝙞𝙨 𝙖𝙗𝙞𝙡𝙞𝙩𝙮 𝙩𝙤 𝙘𝙤𝙢𝙢𝙪𝙣𝙞𝙘𝙖𝙩𝙚 𝙬𝙞𝙩𝙝 𝙛𝙖𝙢𝙞𝙡𝙮 𝙖𝙣… See more.

The Neuro-Network.

𝐁𝐫𝐚𝐢𝐧 𝐢𝐦𝐩𝐥𝐚𝐧𝐭 𝐡𝐞𝐥𝐩𝐬 𝐜𝐨𝐦𝐩𝐥𝐞𝐭𝐞𝐥𝐲 ‘𝐥𝐨𝐜𝐤𝐞𝐝-𝐢𝐧’ 𝐦𝐚𝐧 𝐜𝐨𝐦𝐦𝐮𝐧𝐢𝐜𝐚𝐭𝐞

Continue reading “Brain implant helps completely ‘locked-in’ man communicate” »

Al Sandrock, the top scientist at Biogen who exited last year in a dispute over its controversial Alzheimer’s treatment, has landed a new job as the CEO of Voyager Therapeutics, the company said Tuesday.

Voyager’s appointment of Sandrock as its new CEO is the latest in a series of moves aimed at refocusing the company on a new gene therapy delivery technology, following setbacks with its earlier pipeline.

Did they purposely set out to create inventions that will bring death and blood shed?🤔

Usually when drafting a Patent Claim for any invention, the Inventor states the benefits of the invention to the society.

Looking at the picture below i am tempted to ask, of what use are Nuclear bombs and other weapons of mass destruction of benefit to the society?

Continue reading “Looking at Russia’s war on Ukraine and just wondering if the inventors of these weapons of mass destructions really intended for it to be used for this purpose” »

Rejuvenation biotechnology: good progress, but a long way still to go.

Scientists at La Jolla Institute for Immunology (LJI) have found that people with Parkinson’s disease have a clear “genetic signature” of the disease in their memory T cells. The scientists hope that targeting these genes may open the door to new Parkinson’s treatments and diagnostics.